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Abstract
Following an injury to their axons close to the cell body, adult motoneurons generally die.  This 
type of injury, typically caused by avulsion of the spinal ventral root, initiates the activation of 
astrocytes and microglial cells and the extracellular space becomes loaded with excessive amounts 
of excitotoxic glutamate.  We have provided evidence that, following ventral root avulsion and 
reimplantation, murine embryonic neuroectodermal stem cells (NE-GFP-4C) grafted into the rat 
spinal cord rescue the vast majority of the motoneurons that would otherwise die, and enable them 
to reinnervate peripheral targets. Stem cell grafts produced the modulatory cytokines IL-1-alpha, 
IL-6, IL-10, TNF-alpha and MIP-1-alpha, but not neurotrophic factors.  The neurons and astrocytes 
in the ventral horn of grafted animals also produced IL-6 and MIP-1-alpha, indicating a strong 
interaction between the graft and the host tissue.  The infusion of function-blocking antibodies 
against all cytokines into the grafted cords completely abolished their motoneuron-rescuing effect, 
while neutralization of only IL-10 suggested its strong effectivity as concerns motoneuron survival 
and a milder effect on reinnervation.
It is suggested that, apart from the anti-inflammatory function of IL-10, the pro-inflammatory
cytokines produced exert a strong modulatory function in the CNS, promoting the prevention of
neuronal cell death.
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Introduction
If their axons are injured relatively distant from the cell body, adult motoneurons usually survive.
However, axonal injuries close to the cell body, such as root avulsion injuries, induce the death of
the vast majority of the affected motoneurons (Koliatsos et al, 1994;  Nógrádi et al, 2007). The
injured motoneurons become vulnerable to the excessive amounts of glutamate delivered into the
extracellular space from the nerve terminals, initiated by nitric oxide(McNaught and Brown, 1998):
glutamate activates N-methyl-D-aspartate (NMDA) receptors (Tikka and Koistinaho, 2001), which
in turn induce an excessive influx of calcium into the damaged cells (Hahn et al, 1988).   The
glutamate   excitotoxicity   is   further   augmented   by   the   microglial   reactivity   around   the   injured
motoneurons (Penas et al, 2009), eventually leading to cell death (Brown and Neher, 2010; Giulian
et al, 1993; Regan and Choi, 1991).  
Potent molecules that antagonize the effects of glutamate toxicity are known to be able to rescue
around 70% of the injured motoneurons, provided that the treatment is applied within 10-12 days
after the occurence of the injury (Nógrádi et al, 2007;  Nógrádi and Vrbová, 2001;  Pintér et al,
2010).   Other treatment strategies involving for example neurotrophins, particularly GDNF and
BDNF   produced   by   grafted   stem   cells   or   applied   directly   to   the   injured   cord,   also   prevent
motoneuron death (Blits et al, 2004; Eggers et al, 2008; Hell et al, 2009; Su et al, 2009), although
neurotrophins typically do not promote axonal regeneration, but rather sprouting at the site of
application.  On the other hand, it is generally accepted that neural progenitor or stem cells shown
to produce neurotrophic factors in vitro are effective to promote survival of injured motoneurons
(Blits et al, 2004; Hell et al, 2009; Su et al, 2009).  However, other potential mechanisms to rescue
damaged motoneurons by changing the microenvironment of these cells are not explored.   To
address this question, we investigated whether a well established clonal neuroectodermal stem cell
line, known to promote regeneration in the lesioned brain (Demeter et al, 2004, Zádori et al, 2011)
is able to prevent motoneuron death after avulsion injury, and if so what factors are responsible for
the motoneuron-rescuing effect.   We here report a remarkable capacity of neuroectodermal stem
cells to promote the survival and regeneration of injured motoneurons otherwise destined to die by
secreting a set of cytokines.   Moreover, it is shown that stem cell grafts interact with the host
environment and induce a pattern of cytokine expression by host neurons and astrocytes similar to
that of grafted stem cells.
Materials and methods
Maintenance of NE-GFP-4C stem cells 
The clonal neuroectodermal stem cells (NE-GFP-4C cells, a gift from Dr. E. Madarász, Institute of
Experimental   Medicine,   Hungarian   Academy   of   Sciences;   also   available   from   ATCC,   No.
CRL-2926) were originally isolated from 9-day-old forebrain vesicles of embryos of transgenic
mice lacking tumour suppressor gene p53, and were made to produce eGFP as described previously
(Schlett and Madarasz, 1997  )  . NE-GFP-4C stem cells were maintained on nuncloned petri dishes
(VWR International, Debrecen, Hungary) in High-glucose Dulbecco Modified Essential Medium
(H-DMEM,   Sigma,   Hungary)   supplemented   with   10%   foetal   calf   serum   (Invitrogen/life
Technologies, Paisley, UK) at 37 °C and 5% CO 2.  Floating cells appeared after 3 days and cultures
were passaged every 2 days. All cell cultures underwent at least two, but no more than five passages
before transplantation.
Ventral root avulsion-reimplantation and transplantation of NE-GFP-4C stem cells
A total of 136 Sprague-Dawley rats (Biological Services, University of Szeged, 180-220 g body
weight) were used.  Ninety-three animals received stem cell grafts and 36 were used as operated
controls (avulsion and reimplantation only). Seventy  animals participated in retrograde labelling
and immunohistochemistry, 48 operated and 9 intact animals in semiquantitative and qPCR studies,
8 animals in tension recording studies, and 15 animals in functional blocking experiments. 
All   the   operations   were   carried   out   under   deep   ketamine-xylazine   anaesthesia   (ketamine
hydrochloride, 110 mg/kg body weight; xylazine [Rompun] 12 mg/kg body weight) and sterile
precautions. Laminectomy was performed at the level of T13–L1, the dura was opened and the left
L4 ventral root was pulled out, leaving the dorsal roots intact. The free end of the ventral root was
then inserted into the ventrolateral part of segment L4 and 5x10 4, 1x, 2x or 3x10 5 stem cells were
injected into the segment at the site of grafting.  The spinal cord was covered with the remaining
dura, the wound was closed and the animals were allowed to recover (Nógrádi and Vrbová, 1996,
2001). The control experiments involved either intact animals or rats whose L4 root was avulsed
and reimplanted without a stem cell graft. Animals survived for 2, 5, 10, 14 or 16 days or for 1, 3 or
6 months. No immunosupressive treatment was applied.  The experiments were carried out with the
approval of the Committee for Animal Experiments at the University of Szeged regarding the care
and use of animals for experimental procedures.   All the procedures were carried out in full
accordance with the Helsinki Declaration on Animal Rights.  Adequate care was taken to minimize
pain and discomfort.
Retrograde labelling 
Three months after the surgery, the 5 animals per group were deeply anaesthetized as described
above. On the operated side, the ventral ramus of the left L4 spinal nerve was sectioned and the
proximal stump of the nerve was covered with a few Fast Blue crystals. Four days  after the
application   of   this   fluorescent   dye,   the   animals   were   reanaesthetized   and   were   perfused
transcardially with 4% paraformaldehyde in 0.1 mol/l phosphate buffer (pH=7.4).
Semiquantitative PCR, list of factors
Spinal cords were homogenized twice for 10 sec in 600 µl RLT buffer + ß-MeETOH (Qiagen
GmbH, Hilden, Germany) with a MagNaLyser (Roche, Rotkreuz, Switzerland) at a speed of 5,500
rpm with an intermediate pause for 5 min on ice. The resulting lysates were incubated on ice and
subjected   to   centrifugation   at   13,000   rpm   for   1   min   at   room   temperature.  The   lysates   were
subsequently used for RNA extraction with the QIAcube robot system (Qiagen) and the RNeasy
Mini   Kit   protocol   for   large   samples   (Qiagen).   After   DNaseI   treatment   (Turbo   DNA-free   Kit,
Ambion, Austin, TX, USA), the RNA was measured both qualitatively and quantitatively with an
Agilent 2100 Bioanalyzer (Agilent, Vienna, Austria). An RNA Lab chip (Agilent RNA 6000 Nano
Reagents)   was   used   to   determine   the   RNA  integrity   number.   cDNA  was   synthetized   with   a
High-Capacity   Reverse   Transcription   Kit   (Applied   Biosystems,   Foster   City,   CA,   USA)   The
appropriate 5' and 3 '  primers for PCR were designed manually and then tested with AmplifX
software. The appropriate conditions (e.g. annealing temperatures) for each cytokine, chemokine
and neurotrophic factor were ﬁrst established by gradient-PCR, using a positive control consisting
of mouse and rat embryo tissue or injured mouse and rat spinal cord. To establish the quantification
in the linear range, different cycle numbers were used depending on the target genes: IL-1-alpha,
IL-1-beta,   TGF-beta,   MIP-1-alpha   and   PDGF-alpha   were   ampliﬁed   at   30   cycles,   while
hypoxanthine-guanine phosphoribosyltransferase (HPRT), the other cytokines (IL-6, IL-10, MCP-1,
MCSF and TNF-alpha) and the neurotrophic factors (BDNF, GDNF, NT-3, NT-4/5, PDGF-beta, and
PTN)   were   amplified   at   35   cycles.  The   RT-PCR   results   for   the   cytokines,   chemokines   and
neurotrophic factors at each time point (2, 5, 10 and 14 days after surgery) were expressed as a
proportion of the corresponding intensity value of the HPRT product (densitometric measurement).
Laser capture microdissection (LCM), quality control of RNA
All tissues were quick-frozen in liquid nitrogen and stored at -80 °C until further use.   LCM was
performed with the Veritas instrument (Arcturus, CA, USA), equipped with a cutting laser (349 nm)
to cut a narrower outline around the region of interest and a capture laser (810 nm) to capture the
entire region within the outline. The procedure has been described previously (Jais et al, 2011). In
brief, 10 µm thick tissue sections were cut on a  Leica CryoCut Jung CM1800 cryostat (Leica
Instruments,   Nußloch,   Germany)   by  using   an   RNAse-free   technique,   mounted   onto   special
membrane   slides   (Molecular   Machines   &   Industries,   Glattbrugg,   Switzerland)   and   stained
immediately after cutting with the HistoGene LCM Frozen Section Staining kit (MDS Analytical
Technologies, Ismaning, Germany). The sections were then cleared in xylene for 5 min and either
used directly for microdissection or stored at -80 °C until further use. Regions of interest were cut
and captured into CapSure Macro LCM caps (MDS, Ismaning, Germany).  The laser power setting
ranged   from   60   to   80   mW,   and   the   pulse   settings   from   1,700   to   2,500   μsec.   Spot   size   was
determined prior to microdissection and adapted to each tissue type. During an LCM session,
dissection of an area of approximately 200,000 – 250,000 μm² (~ 1,000 cells) led to amplifiable
results in the subsequent qPCR.   The remaining tissue on the slide was used for RNA quality
measurement using the RNeasy Micro Kit (Qiagen) for RNA isolation. The protocol including the
DNaseI treatment was carried out directly on the columns. After the overall procedures, the RNA
quality measurements were analysed with the Agilent 2100 Bioanalyzer applying the RNA 6000
pico Lab chip (Agilent).
Design of primers used for quantitative RT-PCR studies
The primers of the assays used in this study were designed through the use of the Primer Express
software version 2.0 (Applied Biosystems). The house-keeping gene assays were designed to detect
mouse and rat mRNA transcripts and were based on mRNA alignments (SECentral software, Cary,
NC, USA) using the following reference genes: mouse BC082592 and rat X02231 sequences for
GAPDH, and mouse NM_013556 and rat BC098629 for the HPRT assay. In order to exclude the
detection of DNA, the primers were located on different exons. The primers used for the GAPDH
assay were: sense: 5’- GGC CTT CCG TGT TCC TAC C -3´ and antisense: 5’- GCC TGC TTC
ACC ACC TTC TT - 3´; and for HPRT: sense: 5’- GGT GGA GAT GAT CTC TCA ACT TTA AC
-3´ and antisense: 5’- TGT ATC CAA CAC TTC GAG AGG TCC -3´.
The genes of interest were designed to detect mouse and rat sequences, too. The primers used for
the different assays were: MIP: sense: 5’- TGC CCT TGC TGT TCT TCT C - 3’ and antisense: 5’-
ATT CTT GGA CCC AGG TCT CTT - 3’; PDGF: sense: 5’ – TAG ACT CCG TAG GGG CTG A –
5’ and antisense: CAA TAC TTC TCT TCC TGC GAA TGG - 5’; TNFa: sense: 3’- ACT GAA CTT
CGG GGT GAT CG - 5’ and antisense: 5’- TTG AAG AGA ACC TGG GAG TAG A -3’; IL-1:
sense: 5’- AGA CCA TCC AAC CCA GAT CA - 3’ and antisense: 5’- CGG TCT CAC TAC CTG
TGA TG -3’; IL10: sense: 5’- ATG  GCC CAG AAA TCA AGG-3’ and antisense: 5’- CGA GGT
TTT CCA AGG AGT TG -3’; IL6: sense: TTC CCT ACT TCA CAA GTC CGG-3’ and antisense:
5’- TAC AAT CAG AAT TGC CAT TGC A-3’; PDGFnew: sense: 5’- CTG GCT CGA AGT CAG
ATC CAC -3’ and antisense: 5’- GGG CTC TCA GAC TTG TCT CCA -3’.
All assays were validated by using standard dilution series of a positive control over at least 4 log
decades. The reaction efficiency was calculated from each standard curve via the formula: E:
10-1/slope -1.
Quantitative RT-PCR (qRT-PCR)
A two-step qRT-PCR was performed with the High-Capacity Reverse Transcription Kit (Applied
Biosystems) for cDNA synthesis and adjacent qPCR measurements were performed with the Power
Sybr   Green   Kit   (Applied   Biosystems).   The   cDNA  was   synthetized   on   a   StepOnePlus   cycler
(Applied Biosystems) and the qPCR was performed on the 7900HT Sequence Detection System
(Applied   Biosystems).  The   expression   levels   of   different   genes   of   interest (MIP-1-alpha,
TNF-alpha, IL-1-alpha, IL-6 and IL-10)  were measured by qRT-PCR (Klein, 2002). The relative
expression levels of these genes were calculated in relation to two different house-keeping genes
(glyceraldehyde-3-phosphate-dehydrogenase [GAPDH] and HPRT) using the ddCt method. As the
data obtained with the use of GAPDH appeared to be more reliable, these are presented here.
Immunohistochemistry
For spinal cords 25 μm transverse sections were cut on a cryostat (Leica CM 1850, Leica GmbH,
Nussloch, Germany) and mounted onto gelatin-coated glass slides. Non-specific binding sites were
subsequently blocked  with 3%  normal donkey,  goat or horse serum. Primary antibodies  were
incubated overnight at 4  oC, washed, and then incubated with fluorescent-conjugated secondary
antibodies for 1 h at room temperature. The following primary antibodies were used: anti-mouse
IL-1-alpha  (R&D   Systems   Cat#   AF-400-NA  RRID:AB_354473),   IL-6  (R&D   Systems   Cat#
AF-406-NA  RRID:AB_354478),  TNF-alpha  (R&D  Systems  Cat#  AF-410-NA
RRID:AB_354479), MIP-1 alpha (R&D Systems Cat# AF-450-NA RRID:AB_354492) (1:50, all
from   R&D   Systems,  Minneapolis,   MN,   USA),   anti-mouse   IL-10  (BioLegend   Cat#   505011
RRID:AB_389223), (1:400, Biolegend, San Diego, CA, USA),  mouse  anti-GFAP  (Santa Cruz
Biotechnology, Inc. Cat# sc-71141 RRID:AB_1124625)  (1:100  Santa Cruz Biotechnology, Inc,
CA,   USA),   polyclonal   chicken   anti-green   fluorescent   protein   (GFP)  (EMD   Millipore   Cat#
AB16901 RRID:AB_90890)  (1:2,000 Chemicon), biotinylated Griffonia (Bandeira) simplicifolia
lectin   B4 ((GSA-B4,   1:200,   Vector   Labs,   Burlingame,   CA,   USA),   anti-mouse/rat   IL-1-alpha
(Abbiotec Cat# 250715 RRID:AB_2124091), IL-6 (Abbiotec Cat# 250717 RRID:AB_2127453),
IL-10  (Abbiotec   Cat#   250713   RRID:AB_2125107),   TNF-alpha  (Abbiotec   Cat#   250844
RRID:AB_2204102) and MIP-1-alpha (Abbiotec Cat# 251416 RRID:AB_10637571) (1:200, all
from Abbiotec, San Diego, CA, USA), goat anti-choline acetyltransferase (Merck Cat# AB144P
RRID:AB_11214092)  (1:200, Millipore, Billerica, MA, USA), anti-mouse M6 (mouse-specific
neuron marker, 1:400 DSHB, IA, USA), anti-mouse M2 (mouse-specific astrocyte marker, 1:400,
DSHB), anti-mouse MOG (R&D Systems Cat# MAB2439 RRID:AB_2145548) (mouse-specific
oligodendrocyte marker, 1:50, R&D Systems, Minneapolis, MN) and anti-SSEA-1 (stage-specific
mouse embryonic antigen-1, 1:400, DSHB). Secondary antibodies were used as follows: Alexa
Fluor 594 donkey anti-rat  (Life Technologies Cat# A21209 RRID:AB_10562899), Alexa Fluor
546 goat anti-rabbit  (Life Technologies Cat# A10040 RRID:AB_11181145), Alexa Fluor 546
donkey anti-goat  (Life Technologies Cat# A11056 RRID:AB_10584485), Alexa Fluor 488 goat
anti-chicken (Life Technologies Cat# A11039 RRID:AB_10563770), horse biotinylated anti-goat
IgG (H+L) ( and horse biotinylated anti-mouse IgG (H+L).   Immunohistochemistry and lectin
histochemistry were also visualized with either the streptavidin Alexa Fluor 546 conjugate or the
streptavidin Alexa Fluor 488 conjugate (1:400, Invitrogen).  To validate TNF-alpha and IL-1-alpha
immunohistochemistry, Mg 3HeLa cells transfected with TNF-alpha plasmid (a kind gift from Ernő
Duda, at the Biological Research Centre, Szeged, Hungary) and rat testis were used, respectively.
Fluorescence signals were detected in an Olympus BX50 epifluorescence microscope equipped
with a DP70 digital camera (Olympus Ltd, Tokyo, Japan).   Confocal microscopic images were
obtained by using an Olympus FluoView® FV10i compact confocal microscope.
Function-blocking antibody experiments
Adult   female   rats   (n=5   in   each   set   of   experiments)   were   deeply   anaesthetized   and   the
avulsion-reimplantation of the L4 ventral root and transplantation of 3x10 5 NE-GFP-4C cells were
performed as described above.  A mini-osmotic pump (Alzet Osmotic Pumps, Cupertino, CA, USA;
type 1002, 100 μl volume) ﬁlled with a mixture of function-blocking antibodies against IL-1a
(R&D Systems Cat# AF-400-NA RRID:AB_354473), IL-6  (R&D Systems Cat# AF-406-NA
RRID:AB_354478), TNF-alpha  (R&D Systems Cat# AF-410-NA RRID:AB_354479), MIP-1
alpha (R&D Systems Cat# AF-450-NA RRID:AB_354492) (4 μg/ml working concentration, all
from  R&D  Systems,  Minneapolis,  MN,  USA)  and  IL-10  (BioLegend  Cat#  505011
RRID:AB_389223)  (Biolegend, San Diego, CA, USA) was placed subcutaneously in the dorsal
region (ARG + 5 factors neutralization). All antibodies were specific to mouse epitopes only.  A
silicone tube (Degania Silicone Ltd, Kibbutz Degania, Israel, 0.3 mm in internal diameter) extended
from the mini-pump to the spinal cord and its distal end was inserted into the cord at the site of
grafting.  The tube was fixed to the surrounding musculature with 8-0 sutures (Ethilon) to avoid
moving in or out of the spinal cord. In another set of experiments osmotic pumps filled with IL-10
antibody  only (4 μg/ml working concentration, ARG + IL-10 neutralization) were used. Control
animals   received   pumps   filled   with   identical   volumes   of   antibody-specific   IgG   isotypes   only
(ARG+IgG; polyclonal goat IgG  (R&D  Systems Cat# AB-108-C RRID:AB_354267)  for the
replacement of MIP-1a, IL-1a, IL-6 and TNF-alpha antibodies and monoclonal rat IgG2A (R&D
Systems   Cat#   MAB006   RRID:AB_357349)  for   the   replacement   of   IL-10   antibody,   4   μg/ml
working   concentration,   all   from   R&D   Systems,   Minneapolis,   MN,   USA).  The   pumps   were
removed 2 weeks after the operation.  The animals survived for 3 months and were then processed
for motoneuron counts and histological analyses.
Cell counts
The number of retrogradely labelled cells were determined on 25 µm thick serial cryostat sections.
To avoid double counting of neurons present in consecutive sections, the retrogradely labelled
neurons were mapped with the aid of an Olympus (Olympus Ltd, Tokyo, Japan) drawing tube, and
their locations were compared with those of the labelled neurons in the previous section (Nógrádi et
al, 2007; Pintér et al, 2010).  All sections from the L4 motoneuron pool were used.
Quantification of astrocyte and microglia/macrophage density
To assess the density of GFAP-positive astrocytes and GSA-B4-positive microglia/macrophages in
injured and grafted ventral horns, we photographed injured, grafted and contralateral intact horns
for each rat at a 10-fold primary magnification, using a Olympus BX50 epifluorescence microscope
at a distance of 0.5, 1, 1.5, and 2 mm rostral and caudal to the reimplanted ventral root (n=5/group).
The macrophage marker GSA-B4 isolectin was used as this lectin is able to bind to both microglial
cells   of   the   spinal   cord   and   invading   macrophages.    With   ImageJ   Software  (ImageJ,
RRID:nif-0000-30467),  we  measured  the  relative  densities  of  GFAP  and  GSA-B4
immunoreactivity in the ventral horns. The background/autofluorescence of unstained samples as
reference intensity was then subtracted from the intensity of injured grafted and of intact ventral
horns in order to determine the final density. The GFAP and GSA-B4 intensity of the injured and
grafted ventral horns was then divided by that of the contralateral intact ventral horns. As GSA-B4
labels the endothelial cells of some capillaries, the density of the capillaries was deducted from the
total densities. We additionally performed automatic thresholding for each image by using NIH
ImageJ software to determine the threshold for the specific signal. After the threshold had been set,
the density above the threshold was quantified.
Analysis of locomotion pattern – CatWalk gait analysis
For determination and analysis of the parameters of the hindlimb movement pattern, the 'CatWalk'
automated quantitative gait analysis system (Noldus Ltd, Wageningen, The Netherlands) was used
at the end of the 3 months survival period. This computer-assisted method of locomotor analysis
made it possible to quantify several gait parameters, including the duration and speed of different
phases of the step cycle and print areas detected during locomotion. The following parameters were
taken into account during the analysis:  the print area: the total ﬂoor area contacted by the paw
during the stance phase;
the maximum print area: the area contacted by the paw at the moment of maximum paw-ﬂoor
contact during the stance phase;
the box length and width: the parameters describing the length and width of the print area;
the stride length: the distance between two consecutive paw placements;
the swing duration and speed: the swing duration is the duration of the swing phase, while the
swing speed is computed from the swing duration and the stride length (Hamers et al, 2006; Hamers
et al, 2001).
Muscle tension recording
The animals randomly selected for tension recording (n=4 in both the control and the grafted group)
were anaesthetized with ketamine-xylazine at the end of the 3-month survival period and the tibialis
anterior and extensor digitorum longus muscles  of both the reinnervated and the contralateral
control hindlimb were prepared for tension recording. These muscles were chosen for tension
recording   because   the   motoneurons   innervating   them   are   mainly  found   in   spinal   segment   L4
(Lowrie et al, 1987).  The muscles of the contralateral leg were considered to be suitable controls
because their tension increased with age in a similar way to that for the muscles of the normal,
unoperated animals. The distal tendons were dissected free and attached to strain gauges, and the
exposed parts of the muscles were kept moist with Krebs' saline solution. Isometric contractions
were then elicited from the muscles by stimulating the ventral ramus of the L4 spinal nerve with
bipolar electrodes.  The length of each muscle was adjusted so as to produce the maximum twitch
tension. Single twitch and tetanic (40-100 Hz) contractions were displayed and recorded on a
computer; all the additional recording hardware and software were developed by Supertech Ltd
(Pécs, Hungary, system “Kellényi”).   Maximum tetanic tension was achieved at a stimulation
frequency of about 100 Hz.  An estimate of the numbers of motor axons supplying the muscles was
obtained by stimulating the L4 spinal nerve with stimuli of increasing intensity and recording the
stepwise increments of twitch contractions. 
Statistical analysis
The non-parametric Mann-Whitney U test and the one-way or two-way ANOVA test with Tukey's
all pairwise multiple comparison procedures  were used to compare the data on the groups.   The
tests were used according to the parametric or non-parametric nature of the data.   Values are
reported throughout the manuscript as means ± S.E.M.
Results
In order to determine whether stem cells that do not produce detectable amounts of neuroprotective
molecules in vitro are able to adapt to the environment of damaged motoneurons and prevent cell
death, neuroectodermal stem cells derived from the telencephalic vesicle wall of E9 p53-deficient
mouse embryos were grafted into the lumbar 4 (L4) segment of the spinal cord of rats whose L4
ventral root has been avulsed and subsequently reimplanted (Fig. 1A and see detailed description in
Materials   and   Methods).    The   clonal   stem   cell   line   applied,   NE-GFP-4C   (ATCC   number
CRL-2926), was described and characterized in detail earlier (Schlett and Madarász, 1997).
Survival, differentiation and migration of the grafted stem cells
The grafted stem cells (3x10 5 stem cells in each case) formed a round mass of green fluorescent
protein   (GFP)-positive   cells   in   the   ventral   part   of   segment   L4   and   indicated   early   signs   of
differentiation   by   first   expressing   the   embryonic   stem   cell   marker   SSEA-1   (stage-specific
embryonic antigen-1) at 5 days postoperatively (n=4, Fig. 1B).  The cells of the graft later started to
differentiate   into   glial   and   neuronal   cell   lines,   but   at   10   days   following   grafting   (n=4)   the
graft-derived astrocytes and neurons had not yet migrated away from the grafting site (Fig. 1C).
During the next few days, the differentiated cells ceased their GFP expression and largely migrated
away from the implantation site, leaving there only limited numbers of differentiated cells (16 days
survival, n=4,  Fig. 1D).   Numerous stem cell-derived neurons (501±84) and astrocytes (465±81)
settled throughout segment L4 in the following weeks (1 month survival, n=5, Figs. 1J-1K), while
only very few (45±16) oligodendrocytes of graft origin could be detected.  The stem cells and their
derivatives were rarely seen in contact with the injured motoneurons. Three months after grafting,
the astrocytes and neurons were still confined nearly exclusively to the injured L4 segment. By a
survival time of 6 months (n=5) their numbers had decreased critically.
Stem cell grafts dramatically improve the reinnervation of hindlimb muscles by the rescued
motoneurons
Retrograde labelling from the ventral ramus of the L4 spinal nerve 3 months after grafting revealed
that large numbers of axons of surviving motoneurons (up to 65% of the total L4 motoneuron pool)
were able to enter the reimplanted root and reinnervate muscles in animals that received a stem cell
graft (3x105 stem cells) at the time of avulsion and reimplantation (ARG animals, Figs. 2A-B).  In
the   non-grafted   control   animals   (AR   animals,   n=5),   however,   only   minimal   numbers   of
motoneurons (46±5, 4% of the total intact L4 pool) contributed to the reinnervation of the hindlimb
muscles (Fig. 2A).  Increasing numbers of grafted stem cells (5x10 4, 1x, 2x and 3x10 5 stem cells,
n=5 in each group) proved to induce proportionally increasing numbers of surviving motoneurons
that   reinnervated   the   targets,   suggesting   a   motoneuron-rescuing   mechanism   dependent   on   the
numbers of molecules secreted by the grafted cells (Figs. 2A-B). However, the number of grafted
cells  that could be utilized to rescue the motoneurons  and promote regeneration exhibited an
optimum.  Grafts involving more than 3x10 5  stem cells (e.g. 5x10 5  or 1x10 6  stem cells) caused
damage to the host cord, thereby compromising the regenerative effects of the grafted stem cells.
Such grafts were therefore excluded from the present study.  In the subsequent work reported here
each   ARG   animal   received   3x105  stem   cells.  Morphological   reinnervation   was   confirmed   by
examinations proving functional reinnervation.   The higher numbers of motor units found in the
grafted animals (21±1 [ARG] vs 4±1 [AR] motor units for the tibialis anterior, and 14±1 [ARG] vs
4.5±1 [AR] for the extensor digitorum longus; Figs. 2C-D) produced significantly greater forces in
the   tibialis   anterior   (79%±3   operated/intact   side   [ARG]  vs  7.5%±2.5   [AR])   and   the   extensor
digitorum longus (73%±3 [ARG] vs 13%±4 [AR]) muscles (n=4, Figs. 2E-F).  Detailed functional
hindlimb movement analysis with the CatWalk system showed that the affected hindlimbs of the
ARG animals demonstrated movement pattern features closely approximating to those of intact
animals, whereas the AR animals displayed a considerably impaired movement pattern (Fig. 3).
Stem cell graft downregulates glial microenvironment in the host cord
We next investigated the glial environment of the injured motoneurons in the ventral horn of grafted
and control animals.   Both astroglial and microglial activity are known to moderate cascades of
negative   effects   on   damaged   neurons   of   the   spinal   cord,   although   the   nature   of   the
microglia/macrophages that participate in certain pathological processes is still controversial (Biber
et al, 2007; Gaudet et al, 2011).  We therefore looked at the glial reactions within the spinal cords of
AR and ARG animals in the critical first 10 days after the avulsion injury.  At 5 and 10 days after
grafting,   neuroectodermal   stem   cell   transplantation   led  to   significant  decrease   in the
microglia/macrophage and astroglial reactions throughout segment L4 of ARG animals relative to
AR animals (Fig. 4). 
Determination of secreted factors expressed in the grafted cord
These data suggested that, in view  of  the lack of physical contact between the injured and the
grafted cells, a paracrine secretory mechanism must be exerted by the graft to decrease the activity
of the glial cells of the cord and prevent motoneuron death.  To determine the factors acting in the
grafted cords, we performed a series of semiquantitative PCR analyses of segment L4 in ARG and
AR animals, including neurotrophic and immune factors known to play roles in spinal cord injuries
and their experimental treatment (Bartholdi and Schwab, 1997;  Ousman and David, 2001).   It
emerged that on postoperative days 2, 5, 10 and 14 there was no difference between the AR and
ARG animals (n=4 in each group) in the mRNA levels of the investigated neurotrophic factors, but
the mRNA levels of the interleukins IL-1-alpha, IL-6 and IL-10, tumour necrosis factor-alpha
(TNF-alpha)   and   macrophage   inflammatory   protein-1-alpha   (MIP-1-alpha)   were   significantly
higher in the ARG than in the AR animals, typically at 5 and 10 days following grafting.  However,
the mRNA production of these factors had declined by 14 days after grafting (Fig. 5).
Differential mRNA expression of cytokines in the stem cells graft and in the ventral horns
To distinguish between graft and host immune factor production, we used the laser microdissection
technique to perform a qPCR analysis on identical parts of spinal cord sections (ventral horns) taken
from AR and ARG animals and from the stem cell graft (n=5 in each group)  The stem cell grafts
and   the   ventral   horns   of   the   ARG   animals   produced   considerable   amounts   of   the   cytokines
investigated, with appreciable increases by 10 days as compared with 5 days after grafting (Figs.
6A-E); IL-10 proved to be an exception, as it was produced in greater amounts by the grafted cells 5
days after grafting.  In contrast, the ventral horns of the AR animals produced increased amounts of
the mRNAs of these factors at 5 days, with a moderate decline by 10 days after the avulsion injury;
IL-10 was again an exception: it was not produced in the control cords at all (Fig. 6C).   The
cultured NE-GFP-4C cells did not display detectable levels of the mRNAs of any of the factors.  At
a survival time of 10 days, the ventral horns of the ARG animals exhibited increased mRNA levels
of all the factors, including IL-10, relative to the mRNA levels of the AR animals, suggesting a
graft-induced upregulation of these factors at the mRNA level in the host cord.
Protein expression patterns of cytokines in the grafted cells and in the spinal cord 
To test whether the mRNA levels are translated into protein production, the protein expression
patterns   of   these   cytokines   were   studied   by   immunohistochemistry.    Through   the   use   of
mouse-specific antibodies, strong immunoreactivity to all five factors was found to be exerted by
the grafted cells at 5 days after grafting (Figs. 6F-J).  It was noteworthy that the majority, but not all
of   the   grafted   cells   were   immunopositive   for   the   cytokines   tested.   However,   at   10   days
postoperatively only the strong expression patterns of IL-6, TNF-alpha and MIP-1-alpha were
maintained. The immunofluorescence of IL-1-alpha and IL-10 was confined to some of the stem
cells   located   at   the   periphery   of   the   graft.     On   the   other   hand,   immunohistochemistry   with
anti-rat/mouse specific antibodies indicated that the ventral horn neurons and glial cells of the ARG
animals appeared to produce only IL-6, IL-10 and MIP-1-alpha.   The expression patterns were
uniform at both 5 and 10 days after grafting.   Confocal microscopic analysis of double-labelled
sections   revealed   that   the   glial   IL-6,   IL-10   and   MIP-1-alpha   reactivity   was   confined   to   the
astrocytes, and not to the microglia/macrophages of the host cord, even though the degree of
astrogliosis in the ARG animals was limited.  A similar distribution pattern of these cytokines was
observed in the AR animals, but the astroglial density was increased. Despite the relatively high
mRNA levels of IL-1-alpha and TNF-alpha, no immunoreactivity to these factors could be detected
as compared with the biological positive controls (see Experimental Procedures). 
Function-blocking antibodies abolish the neuroprotective effects of the grafted stem cells
To test whether these cytokines are indeed responsible for inducing the prevention of motoneuron
death,   for   2   weeks   we   used   osmotic   pumps   to   infuse   the   mixture   of   function-blocking
mouse-specific antibodies produced against all five factors to the grafts (n=5, ARG + 5-factor
neutralization).  Indeed, retrograde labelling from the ventral ramus of the L4 spinal nerve revealed
virtually   as   few   reinnervating   motoneurons   after   3   months   as   in   the   AR   animals   (57±5
[ARG+5-factor neutralization], 46±5 [AR]; Figs. 7A,D, and E).  However, the question remained as
to whether the considerable amount of IL-10 (the only cytokine with anti-inflammatory effects in
the peripheral immune system) produced by the grafted cells  would alone be able to prevent
motoneuron death.  In a search for an answer to this question, we set up another function-blocking
experiment   (n=5,   ARG   +   IL-10   neutralization)   in   which   only   the   anti-IL-10   mouse-specific
function-blocking antibody was infused by osmotic pump to the grafted cord.   When the IL-10
function was blocked in this way, the reinnervation of denervated hindlimbs was dramatically
improved in comparison with that in the AR and ARG + 5-factor neutralization animals (195±10
reinnervating motoneurons, Fig. 7E).  In order to test whether isotype-specific immunoglobulins do
not have a neutralizing effect on the grafted stem cells, osmotic pumps filled with a mixture of
isotype-specific IgGs were used to deliver these IgGs to the site of grafting, and no significant
difference   relative   to   the   ARG   animals   was   found   (n=5,   ARG+IgG;   670±72,   Fig.   7E).    The
significant difference in reinnervating motoneuron numbers between the two neutralization groups
reveals a strong modulatory role for the other four factors in the injured cord (Figs. 7E-F); the
blocking of IL-10 produced by the grafted cells was only partially able to inhibit the beneficial
effect of the graft.  To establish whether the major beneficial effect of IL-10 involves the survival
and/or the reinnervating capacity of the motoneurons, we made use of anti-choline acetyltransferase
(ChAT) immunofluorescence to detect and count the surviving and intact motoneurons, including
those “silent motoneurons” that are not able to regenerate their axons into the vacated endoneural
sheaths of the reimplanted L4 root.  The proportion of surviving motoneurons on the operated side
compared to the total intact ChAT + motoneuron pool in segment L4 was dramatically increased in
the ARG animals but not in the other experimental groups (Fig. 7G), indicating that IL-10 is mainly
responsible for the survival of the motoneurons in this experimental paradigm. On the other hand,
the proportion of surviving motoneurons that are able to reinnervate peripheral targets  (Fig. 7G)
was again improved after blockade of the IL-10 function, which suggests an important, but not
overwhelming role for IL-10.
Discussion
We have shown here that, following an avulsion injury grafted embryonic neuroectodermal stem
cells successfully prevent motoneuron death by inhibiting microglia/macrophage activity in the
injured ventral horn, and thus probably by decreasing the excess glutamate release onto vulnerable
motoneurons.  
Grafting neuroectodermal stem cells into the spinal cord on one hand induced prominent survival of
injured motoneurons and on the other hand the regenerating axons of rescued motoneurons were
able   to   produce   functional   reinnervation   of   the   denervated   hindlimb   muscles.   However,   stem
cell-derived neurons were never found to contribute to the reinnervation of reimplanted ventral root.
It appeared therefore obvious that the grafted stem cells secreted a number of factors at the site of
the lesion in a paracrine fashion that have a direct effect on the survival of the injured motoneuron
pool destined to death. It has previously been reported that motoneurons affected by an avulsion
injury of the spinal ventral root containing their axons eventually leads to their death in 10-12 days
following   injury  ( Koliatsos   et   al,   1994 ;   Zhou   et   al,   2009  )   and   they  can   be   rescued   with   an
anti-excitotoxic treatment provided it starts within 10 days after avulsion (Nogradi et al, 2007). 
It remains to be answered, however, to what extent and by what mechanisms the pro-inflammatory
cytokines, found to be expressed by the grafted stem cells may contribute to the improved survival
and regenerative capacity of injured motoneurons.   
It has clearly been   shown that IL-10, an anti-inflammatory cytokine in the peripheral immune
system has a neuroprotective effect in the CNS, too. IL-10 has been reported to inhibit caspase-3
and   NF-κB   DNA  binding   in   neurons  in   vitro,   thereby   preventing   the   cell   death   induced   by
glutamate excitotoxicity (Bachis et al, 2001).  Moreover, administration of IL-10 after traumatic or
excitotoxic spinal cord injury promoted survival of injured neurons and improved recovery of motor
function acting through the IL-10 receptor on the injured neurons, thereby preventing the activation
of the apoptotic  cascades (   Bethea et al, 1999 ;   Jackson et al, 2005  ;   Zhou et al, 2009  ). It appears
from these in vitro and in vivo studies that IL-10 possesses a direct neuroprotective effect in the
CNS in addition to the well-established anti-inflammatory effects. 
The   mechanisms   of   action   in   the   CNS   of   IL-1-alpha, IL-6 and   TNF-alpha,   known   to   be
pro-inflammatory cytokines in the peripheral immune system (Commins et al, 2010), are not yet
fully understood (Aldskogius, 2011;  Glezer et al, 2007;  Juttler et al, 2002).  In vitro evidence is
accumulating   that   IL-1-alpha,   IL-1-beta,   IL-6   and   TNF-alpha   are   neuroprotective   against
excitotoxicity-induced cell death in the CNS via distinct pathways (Carlson et al, 1998, 1999, Liu et
al 2011), and that the administration of IL-1-beta, IL-6 and TNF-alpha to the injured murine spinal
cord leads to decreases in the levels of microglia/macrophage activation and tissue loss (Klusman
and Schwab, 1997).  These data strongly support the view that acute or sub-chronic exposure of the
highly vulnerable injured motoneuron pool to these pro-inflammatory cytokines is not deleterious,
although longer expression patterns of these cytokines may already induce toxic effects. The fact
that the grafted stem cells remain clustered at the site of grafting for 10 days and show only limited
differentiation along with a significant rate of cytokine expression levels suggest that this short
period of time of stem cell differentiation provides satisfactory neuroprotection for the injured
motoneurons along with considerable depression of macrophage and astrocyte activation.   It is
noteworthy that the stem cell grafts induced expression of some of the cytokines, including IL-10 in
the host ventral horn, and this was likely to contribute to their neuroprotective effects. The rapid
differentiation process and migration of stem cells appears to cease cytokine expression after this
beneficial period of time.
These   data,   in   conjunction   with   our   findings,   strongly   suggest   that   pro-inflammatory   and
anti-inflammatory   cytokines   selectively   secreted   by   grafted   stem   cells  act   in   concert   to   save
motoneurons and to promote reinnervation of the target muscles. These results raise the opportunity
to investigate whether a local treatment of injured motoneurons with a well-defined set and dose of
cytokines may bring about the similarly great extent of cell rescue and reinnervation as treatment
with stem cells.
References
Aldskogius H (2011) Mechanisms and consequences of microglial responses to peripheral axotomy.
Front. Biosci. Schol. Ed. 3:857-868.
Bachis A, Colangelo AM, Vicini S, Doe PP, De Bernardi MA, Brooker G, Mocchetti, I (2001)
Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like
activity. J. Neurosci. 21:3104-3112.
Bartholdi D, Schwab ME (1997) Expression of pro-inflammatory cytokine and chemokine mRNA
upon experimental spinal cord injury in mouse: an in situ hybridization study.  Eur. J. Neurosci.
9:1422-1438.
Bethea JR, Nagashima H, Acosta MC, Briceno C, Gomez F, Marcillo AE, Loor K, Green J, Dietrich
WD   (1999)   Systemically   administered   interleukin-10   reduces   tumor   necrosis   factor-alpha
production and significantly improves functional recovery following traumatic spinal cord injury in
rats. J. Neurotrauma 16:851-863.
Biber K, Neumann H, Inoue K, Boddeke HW (2007) Neuronal 'On'  and 'Off'  signals  control
microglia. Trends Neurosci. 30:596-602.
Blits B,  Carlstedt TP,  Ruitenberg MJ, de Winter F,  Hermens WT,  Dijkhuizen PA,  Claasens JW,
Eggers R, van der Sluis R, Tenenbaum L, Boer GJ, Verhaagen J (2004) Rescue and sprouting of
motoneurons   following   ventral   root   avulsion   and   reimplantation   combined   with   intraspinal
adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or
brain-derived neurotrophic factor. Exp. Neurol. 189:303-316.
Brown GC, Neher JJ (2010) Inflammatory neurodegeneration and mechanisms of microglial killing
of neurons. Mol. Neurobiol. 41:242-247.
Carlson  NG, Wieggel WA, Chen  J, Bacchi A, Rogers  SW,  Gahring LC (1999) Inflammatory
cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin
through distinct pathways. J. Immunol. 163:3963-3968.
Commins   SP,   Borish   L,   Steinke   JW   (2010)   Immunologic   messenger   molecules:   cytokines,
interferons, and chemokines. J. Allergy Clin. Immunol. 125:S53-72.
Demeter K, Herberth B, Duda E, Domonkos A, Jaffredo T, Herman JP, Madarász E (2004) Fate of
cloned   embryonic   neuroectodermal   cells   implanted   into   the   adult,   newborn   and   embryonic
forebrain. Exp. Neurol. 188(2):254-67.
Eggers R, Hendriks WT, Tannemaat MR, van Heerikhuize JJ, Pool CW, Carlstedt TP, Zaldumbide
A,   Hoeben   RC,   Boer   GJ,   Verhaagen   J   (2008)   Neuroregenerative   effects   of   lentiviral
vector-mediated GDNF expression in reimplanted ventral roots. Mol. Cell. Neurosci. 39:105-117.
Gaudet   AD,   Popovich   PG,   Ramer   MS   (2011)  Wallerian   degeneration:   gaining   perspective   on
inflammatory events after peripheral nerve injury. J. Neuroinflammation 8:110.
Giulian D, Vaca K, Corpuz M (1993) Brain glia release factors with opposing actions upon neuronal
survival. J. Neurosci. 13:29-37.
Glezer I, Simard  AR, Rivest  S  (2007) Neuroprotective role  of the  innate  immune  system by
microglia. Neuroscience 147:867-883.
Hahn   JS,   Aizenman   E,   Lipton   SA  (1988)   Central   mammalian   neurons   normally   resistant   to
glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the
N-methyl-D-aspartate antagonist MK-801. Proc. Natl. Acad. Sci. U S A 85:6556-6560.
Hamers FP, Koopmans GC, Joosten EA (2006) CatWalk-assisted gait analysis in the assessment of
spinal cord injury. J. Neurotrauma 23:537-548.
Hamers FP, Lankhorst AJ, van Laar TJ, Veldhuis WB, Gispen WH (2001) Automated quantitative
gait analysis during overground locomotion in the rat: its application to spinal cord contusion and
transection injuries. J. Neurotrauma 18:187-201.
Hell   RC,   Costa   MM,   Goes   AM,   Oliveira   AL   (2009)   Local   injection   of   BDNF   producing
mesenchymal stem cells increases neuronal survival and synaptic stability following ventral root
avulsion. Neurobiol. Dis. 33:290-300.
Jackson CA, Messinger J, Peduzzi JD, Ansardi DC, Morrow CD (2005) Enhanced functional
recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus
replicons encoding IL-10. Virology 336:173-183.
Jais A, Klein D, Wolfesberger B, Walter I (2011) Gene expression profile of vascular endothelial
growth factor (VEGF) and its receptors in various cell types of the canine lymph node using laser
capture microdissection (LCM). Vet. Immunol. Immunopathol. 140:207-214.
Juttler   E,   Tarabin   V,   Schwaninger   M   (2002)   Interleukin-6   (IL-6):   a   possible   neuromodulator
induced by neuronal activity. Neuroscientist 8:268-275.
Klein D (2002) Quantification using real-time PCR technology: applications and limitations. Trends
Mol. Med. 8:257-260.
Klusman I, Schwab ME (1997) Effects of pro-inflammatory cytokines in experimental spinal cord
injury. Brain Res. 762:173-184.
Koliatsos VE, Price WL, Pardo CA, Price DL (1994) Ventral root avulsion: an experimental model
of death of adult motor neurons. J. Comp. Neurol. 342:35-44.
Lowrie MB, Krishnan S, Vrbova G (1987) Permanent changes in muscle and motoneurones induced
by nerve injury during a critical period of development of the rat. Brain Res. 428:91-101.
McNaught KS, Brown GC (1998) Nitric oxide causes glutamate release from brain synaptosomes.
J. Neurochem. 70:1541-1546.
Nogradi A, Szabo A, Pinter S, Vrbova (2007) Delayed riluzole treatment is able to rescue injured
rat spinal motoneurons. Neuroscience 144:431-438.
Nogradi A, Vrbova G (1996) Improved motor function of denervated rat hindlimb muscles induced
by embryonic spinal cord grafts. Eur. J. Neurosci. 8:2198-2203.
Nogradi A, Vrbova G (2001) The effect of riluzole treatment in rats on the survival of injured adult
and grafted embryonic motoneurons. Eur. J. Neurosci. 13:113-118.
Ousman SS, David S (2001) MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune
cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord.  J.
Neurosci. 21:4649-4656.
Penas C, Casas C, Robert I, Fores J, Navarro X (2009) Cytoskeletal and activity-related changes in
spinal motoneurons after root avulsion. J. Neurotrauma 26:763-779.
Pinter S, Gloviczki B, Szabo A, Marton G, Nogradi A (2010) Increased survival and reinnervation
of   cervical   motoneurons   by   riluzole   after   avulsion   of   the   C7   ventral   root. J.   Neurotrauma
27:2273-2282.
Regan RF, Choi DW (1991) Glutamate neurotoxicity in spinal cord cell culture.  Neuroscience
43:585-591.
Schlett K, Madarasz E (1997) Retinoic acid induced neural differentiation in a neuroectodermal cell
line immortalized by p53 deficiency. J. Neurosci. Res. 47:405-415.
Su H, Zhang W, Guo J, Guo A, Yuan Q, Wu W (2009) Neural progenitor cells enhance the survival
and axonal regeneration of injured motoneurons after transplantation into the avulsed ventral horn
of adult rats. J. Neurotrauma 26:67-80.
Tikka  TM,  Koistinaho  JE  (2001)  Minocycline  provides  neuroprotection  against
N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 166:7527-7533.
Zádori A, Agoston VA, Demeter K, Hádinger N, Várady L, Köhídi T, Göbl A, Nagy Z, Madarász E
(2011) Survival and differentiation of neuroectodermal cells with stem cell properties at different
oxygen levels. Exp. Neurol. 227(1):136-48. 
Zhou Z Peng X, Insolera R, Fink DJ, Mata M (2009) IL-10 promotes neuronal survival following
spinal cord injury. Exp. Neurol. 220:183-190.
Figures and figure legends:
Figure 1. 
Differentiation and migration of grafted stem cells and their derivatives in the spinal cord.  
A. Schematic   drawing   showing   the   surgical   procedure   of   avulsion,   stem   cell   grafting   and
reimplantation of the avulsed L4 ventral root.   B,C.  Expression of embryonic stem cell marker
SSEA-1 by the grafted stem cells 5 and 10 days after transplantation. D,E. Initial differentiation of
the grafted stem cells to M6+ neurons and M2+ astrocytes, accompanied by the loss of GFP
expression.   F,G. Dispersion of the differentiated stem cells from the site of grafting, where only
limited numbers of astrocytes and neurons of graft origin remain. H. Numerous M6+ neurons and
M2+ astrocytes are present in the cord 1 month after grafting, whereas MOG+ oligodendrocytes are
rarely found. I. Only a few stem cell-derived neurons and astrocytes, but no oligodendrocytes are
located in the host cord 6 months following transplantation.  J.  Distribution of M2+ astrocytes
(green dots) and M6+ neurons (red dots) in the injured L4 segment one month following grafting in
a representative ARG animal.  Each spinal cord cross-section represents a 100 µm thick segment of
the cord. The vast majority of the stem cell-derived cells are located in the affected L4 segment.  K.
The absolute numbers of stem cell-derived neurons, astrocytes and oligodendrocytes are shown at
various time points after grafting, n=5. Data are presented as mean +/- S.E.M, p<0.05. The one-way
ANOVA  analysis with Tukey's post-hoc tests was performed. Scale bar in B-G= 500 µm, B'-E'=
200 µm, H= 200 µm and 50 µm (insets), I= 100 µm
Figure 2.
Reinnervation of peripheral targets by injured motoneurons rescued by grafted stem cells.
A,B. The extent of reinnervation of peripheral targets depends on the number of grafted stem cells.
In control animals (AR), only 46±5 retrogradely labelled cells were found, while the transplantion
of   3x105  stem   cells   resulted   in   736±32   reinnervating   motoneurons,   n=5.   C,D.  The   extensor
digitorum longus (EDL) and the tibialis anterior (TA) muscles of grafted (ARG) rats are innervated
by significantly greater numbers of motor axons than are the muscles of AR animals; individual
twitch   contractions   of   motor   units   (MU)   are   shown   in  C, n=4.   E,F. Greater   numbers   of
reinnervating motor axons produced greater maximum tetanic muscle contractions in ARG animals,
n=4; individual tetanic curves are shown in F. Data are presented as mean +/- S.E.M, p<0.05. Data
were analysed by applying the non-parametric Mann-Whitney U test or one-way ANOVA analysis
with Tukey's post-hoc tests was used.  Scale bar in B= 100 µm.
Figure 3.
Results of CatWalk automated gait analysis system.  
Various of the gait analysis parameters displayed significant differences between the AR (n=5) and
ARG   animals   (n=5),   but   not   between   the   ARG   and   intact   animals   (n=5),  reflecting   a  nearly
complete restoration of the hindlimb function in the grafted animals 3 months after transplantation.
Error bars, S.E.M, p<0.05. *= significant difference relative to AR animals. The one-way ANOVA
analysis with Tukey's post-hoc test was used. 
Figure 4.
Astrocytic and microglial/macrophage reactions in grafted and control spinal cords.
A,B. Reduced astroglial (GFAP) and microglial (GSA B 4 isolectin) densities are shown in spinal
segment L4 of ARG animals.  Asterisks indicate the significant differences in density between AR
and ARG animals at various distances from the site of avulsion, n=5. Data are presented as mean
+/- S.E.M, p<0.05. The two-way ANOVA analysis with Tukey's post-hoc tests was used.  Scale bar
in B= 250 µm.
Figure 5.
Results of semiquantitative PCR studies on the production of cytokines
Semiquantitative PCR analysis of cytokine mRNA levels in the injured (AR) or grafted (ARG) L4
segment.   Only those factors are shown that displayed a significant difference at any timepoint.
Note the great amount of IL-10 mRNA produced in the grafted L4 segment of the ARG animals
(n=4 in each group). *=significant difference between the ARG and AR animals at the same
timepoint. The non-parametric Mann-Whitney U test was used. 
Figure 6.
Elevated  mRNA levels  and  immunohistochemical  detection  of  cytokines  produced  by  the
grafted stem cells
A-E.  Relative gene expression levels of various cytokines in the ventral horns of AR and ARG
animals and in the grafts removed by laser microdissection.  There were significant increases in the
RNA levels of all factors, and of IL-10 in the ventral horns and in the grafts of ARG animals by 10
days after grafting relative to the data at 5 days, n=4.  IL-10 was produced only in the grafted cords,
mainly by the grafted cells at 5 days after transplantation.  Ventral horns of 5d ARG animals are
taken as 1 unit.  RNA levels of intact ventral horns are not shown as they were negligible.  F-J.
Immunohistochemical detection of the murine factors produced by the grafted cells at 5 days after
transplantation.   Note the partial expression pattern shown by the grafted cells, especially in the
case of MIP-1-alpha, partially due to declining GFP activity.  Data are presented as mean +/- S.E.M,
p<0.05. The one-way ANOVA analysis with Tukey's post-hoc test was used.  Scale bar in B= 500
µm and 50 µm in insets.
Figure 7.
Function-blocking  antibodies  inhibit  the
effects   of   stem   cell   grafts   on   motoneuron
survival and regeneration
A. Retrogradely   labelled   (FB+)   and   surviving
(ChAT+) motoneurons in AR animals. Note the
very few reinnervating motoneurons.  B.  Results
of retrograde labelling in ARG animals (3x10 5
stem cells).   Nearly all surviving (ChAT +) cells
seem to be able to reinnervate the ventral root.
C,D. Limited numbers of reinnervating cells can
be  seen  in  ARG  animals  treated  with
function-blocking   antibodies,   especially   in   the
case   of   neutralization   against   all   5   factors.  E.
Diagram   showing   the   numbers   of   retrogradely
labelled neurons in various experimental paradigms. Neutralization treatment against all 5 factors
resulted in as low numbers of retrogradely labelled neurons as in AR animals, while treatment with
isotype-specific IgGs (ARG+IgG) did not yield significantly less motoneuron survival compared
with ARG animals,  n=5.   F.  The percentage of surviving injured motoneurons is shown by the
proportion of ChAT+ operated/intact motoneurons in animals with various experimental paradigms.
As  neutralization   of   IL-10   considerably  reduces   the   number   of   surviving   motoneurons,   IL-10
appears to be a strong survival factor for injured motoneurons, n=5. G. Percentages of reinnervating
(FB+) motoneurons in various groups (FB +/op. ChAT+ motoneurons).  Note the reinnervating ability
of motoneurons in ARG animals and the moderate ability after neutralization with IL-10 antibody,
n=5. *=significant difference between ARG and AR, ARG+IL-10 neutralization and ARG+5-factor
neutralization groups (SEM, p<0.05).  **=significant difference between ARG+IL-10 neutralization
and ARG+5-factor neutralization groups (S.E.M, p<0.05). The one-way ANOVA analysis with
Tukey's post-hoc test was performed. Scale bar in A-D= 250 µm.  Data are presented as mean +/-
S.E.M.
